
|Videos|December 19, 2022
2022 SUO Annual Meeting recap: Use of doublet therapy in metastatic prostate cancer varies by location
Author(s)Urology Times staff
“This study highlights how treatment remains influenced by where you live,” Diana Magee, MD, MPH, MSc.
Advertisement
In this video, Diana Magee, MD, MPH, MSc, summarizes the
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves first-line Zenflow system for the treatment of BPH
3
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
4
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
5


















